PCSK9 inhibitors may improve cardiovascular outcomes—Can we afford them?

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
PCSK9 inhibitors may improve cardiovascular outcomes—Can we afford them?
Authors
Keywords
Evolocumab, Alirocumab, LDL cholesterol, Affordability, Budget-impact
Journal
INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 220, Issue -, Pages 242-245
Publisher
Elsevier BV
Online
2016-06-24
DOI
10.1016/j.ijcard.2016.06.126

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.